← Insider buys
AKBA

Akebia Therapeutics, Inc. · Healthcare

Director Steven C Gilman sold $55K of Akebia Therapeutics, Inc.

Sold$55,169
$12.08Price
4,567Shares
−11%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Mon, Jun 8. Filed Tue, Jun 9, 12:17 PM ET, during the session. Not investment advice.